RTEMSY
Live / Allowed — Published for opposition (as of 03 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 24 Apr 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 79426153
- Mark type
- Stylized text
- Filed
- 24 Apr 2025
- Published for opposition
- 03 Mar 2026
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; tumor suppressing agents; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immune diseases and disorders; immunomodulators; immunosuppressive agents; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for treating hematological disorders; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations; chemical reagents for medical purposes in the field of oncology.
Owner
Prosecution history
- 03 Mar 2026 — PUBLISHED FOR OPPOSITION
- 25 Feb 2026 — NOTICE OF PUBLICATION
- 06 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Jan 2026 — ASSIGNED TO EXAMINER
- 28 Jan 2026 — APPLICATION FILING RECEIPT MAILED
- 28 Jan 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 24 Jun 2025 — LIMITATION FROM ORIGINAL APPLICATION ENTERED
- 19 Jun 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB